Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Tango Therapeutics (TNGX) Preferred Shares Issued (2020 - 2021)

Tango Therapeutics has reported Preferred Shares Issued over the past 2 years, most recently at $1.6 million for Q2 2021.

  • Quarterly results put Preferred Shares Issued at $1.6 million for Q2 2021, changed N/A from a year ago — trailing twelve months through Dec 2021 was $30.0 million (changed N/A YoY), and the annual figure for FY2021 was $30.0 million, down 62.9%.
  • Preferred Shares Issued for Q2 2021 was $1.6 million at Tango Therapeutics, down from $28.4 million in the prior quarter.
  • Over the last five years, Preferred Shares Issued for TNGX hit a ceiling of $28.4 million in Q1 2021 and a floor of -$90000.0 in Q4 2020.